Drug recall D-0391-2025
Product
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Reason for recall
cGMP Deviations
Lots and codes
Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
Recall details
- Recalling firm
- Preferred Pharmaceuticals, Inc., Anaheim, CA
- Quantity
- 1190 Bottles
- Distribution
- Nationwide in the US
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 18, 2025
Related products
- NDC 68788-8685 Clindamycin Hydrochloride · Clindamycin Hydrochloride 300 mg/1 · Preferred Pharmaceuticals Inc.